Evidence map›Paper›PMID 35563074›Full record

ArticleInternational journal of molecular sciences2022

Garvicins AG1 and AG2: Two Novel Class IId Bacteriocins of

Antonio Maldonado-Barragán, Estíbaliz Alegría-Carrasco, María Del Mar Blanco, Ana Isabel Vela, José Francisco Fernández-Garayzábal, Juan Miguel Rodríguez, Alicia Gibello

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. A One Health Perspective onMicroorganisms · 2026
    Review
  2. Article
  3. Article
  4. Comprehensive Review on the Biocontrol ofFoods (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Review
  7. Design ofFoods (Basel, Switzerland) · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Antonio Maldonado-BarragánInfection and Global Health Division, School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.ORCID 0000-0002-4775-346X
Estíbaliz Alegría-CarrascoDepartment of Animal Health, Veterinary School, Complutense University, Av. Puerta de Hierro, 28040 Madrid, Spain.
María Del Mar BlancoDepartment of Animal Health, Veterinary School, Complutense University, Av. Puerta de Hierro, 28040 Madrid, Spain.ORCID 0000-0003-4335-4346
Ana Isabel VelaDepartment of Animal Health, Veterinary School, Complutense University, Av. Puerta de Hierro, 28040 Madrid, Spain.
José Francisco Fernández-GarayzábalDepartment of Animal Health, Veterinary School, Complutense University, Av. Puerta de Hierro, 28040 Madrid, Spain.ORCID 0000-0003-1597-0643
Juan Miguel RodríguezDepartment of Nutrition and Food Science, Veterinary School, Complutense University, Av. Puerta de Hierro, 28040 Madrid, Spain.ORCID 0000-0002-1285-9686
Alicia GibelloDepartment of Animal Health, Veterinary School, Complutense University, Av. Puerta de Hierro, 28040 Madrid, Spain.
Universidad Complutense de Madrid · ESUniversity of St Andrews · GB

Funding

SPANISH MINISTRY OF SCIENCE, INNOVATION, AND UNIVERSITIES RTI2018-098530-B-I00
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BacteriocinsAnimalsGram-Positive BacteriaHumansLactococcusMannoseBacteriocinsMannoseantimicrobial peptidesin silico analysiszoonotic diseases

Identifiers

PMID35563074
PMCPMC9101539
OpenAlexW4224272099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.